DE69227612T2 - Hexahydrobenzo(f)quinolinone als 5-alpha-reduktase Inhibitoren - Google Patents

Hexahydrobenzo(f)quinolinone als 5-alpha-reduktase Inhibitoren

Info

Publication number
DE69227612T2
DE69227612T2 DE69227612T DE69227612T DE69227612T2 DE 69227612 T2 DE69227612 T2 DE 69227612T2 DE 69227612 T DE69227612 T DE 69227612T DE 69227612 T DE69227612 T DE 69227612T DE 69227612 T2 DE69227612 T2 DE 69227612T2
Authority
DE
Germany
Prior art keywords
methyl
hydrogen
alkyl
hexahydrobenzo
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69227612T
Other languages
German (de)
English (en)
Other versions
DE69227612D1 (de
Inventor
Kenneth Steven Clarksville Maryland 21029 Hirsch
Charles David Indianapolis Indiana 46227 Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69227612D1 publication Critical patent/DE69227612D1/de
Publication of DE69227612T2 publication Critical patent/DE69227612T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DE69227612T 1991-08-21 1992-08-20 Hexahydrobenzo(f)quinolinone als 5-alpha-reduktase Inhibitoren Expired - Fee Related DE69227612T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74813491A 1991-08-21 1991-08-21
US07/780,166 US5250539A (en) 1991-08-21 1991-10-21 Hexahydrobenzo[f]quinolinones

Publications (2)

Publication Number Publication Date
DE69227612D1 DE69227612D1 (de) 1998-12-24
DE69227612T2 true DE69227612T2 (de) 1999-05-06

Family

ID=27114886

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69227612T Expired - Fee Related DE69227612T2 (de) 1991-08-21 1992-08-20 Hexahydrobenzo(f)quinolinone als 5-alpha-reduktase Inhibitoren

Country Status (17)

Country Link
US (1) US5250539A (enExample)
EP (1) EP0531026B1 (enExample)
JP (1) JPH05213889A (enExample)
KR (1) KR930004269A (enExample)
CN (1) CN1069488A (enExample)
AT (1) ATE173467T1 (enExample)
AU (1) AU2118292A (enExample)
BR (1) BR9203266A (enExample)
CA (1) CA2076509A1 (enExample)
CZ (1) CZ256792A3 (enExample)
DE (1) DE69227612T2 (enExample)
FI (1) FI923751A7 (enExample)
HU (1) HUT68064A (enExample)
IL (1) IL102880A0 (enExample)
MX (1) MX9204815A (enExample)
NO (1) NO923266L (enExample)
TW (1) TW218011B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
AU654573B2 (en) * 1991-08-21 1994-11-10 Eli Lilly And Company Benzo(f)quinolinones
GB9317314D0 (en) * 1993-08-20 1993-10-06 Smithkline Beecham Corp Compounds
US5578724A (en) * 1994-09-20 1996-11-26 Eli Lilly And Company Process for preparation of benzo[f]quinolinones
FR2737721B1 (fr) 1995-08-08 1997-09-05 Roussel Uclaf Nouveaux composes biphenyles, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicament et les compositions pharmaceutiques les contenant
EP0926148A1 (en) 1997-12-23 1999-06-30 Applied Research Systems Ars Holding N.V. Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors
GB0222516D0 (en) * 2002-09-27 2002-11-06 Karobio Ab Novel compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0102046A1 (en) * 1982-08-26 1984-03-07 Schering Corporation Tricyclic lactams, method for making them, pharmaceutical compositions containing them
US4511569A (en) * 1982-08-26 1985-04-16 Schering Corporation Tricyclic lactams and derivatives useful in increasing cardiac contractility
US4859681A (en) * 1984-02-27 1989-08-22 Merck & Co., Inc. 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors
US5120742A (en) * 1984-02-27 1992-06-09 Merck & Co., Inc. 17 β-acyl-4-aza-5 α-androst-1-ene-3-ones as 5 α-reductase inhibitors
DE3773950D1 (de) * 1986-01-23 1991-11-28 Hoffmann La Roche Benzazecin-derivate.
US4888336A (en) * 1987-01-28 1989-12-19 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
ES2051843T3 (es) * 1987-05-11 1994-07-01 Ono Pharmaceutical Co Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico.
IN167395B (enExample) * 1987-07-21 1990-10-20 Hoffmann La Roche
US5120840A (en) * 1990-08-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors

Also Published As

Publication number Publication date
FI923751A0 (fi) 1992-08-20
NO923266D0 (no) 1992-08-20
ATE173467T1 (de) 1998-12-15
BR9203266A (pt) 1993-04-06
FI923751L (fi) 1993-02-22
EP0531026B1 (en) 1998-11-18
CZ256792A3 (en) 1993-04-14
NO923266L (no) 1993-02-22
DE69227612D1 (de) 1998-12-24
FI923751A7 (fi) 1993-02-22
MX9204815A (es) 1993-12-01
TW218011B (enExample) 1993-12-21
CA2076509A1 (en) 1993-02-22
IL102880A0 (en) 1993-01-31
AU2118292A (en) 1993-02-25
CN1069488A (zh) 1993-03-03
US5250539A (en) 1993-10-05
HUT68064A (en) 1995-05-29
KR930004269A (ko) 1993-03-22
EP0531026A1 (en) 1993-03-10
JPH05213889A (ja) 1993-08-24

Similar Documents

Publication Publication Date Title
DE69231610T2 (de) Benzo(f)quinolinone als 5-Alpha-reductase Inhibitoren
DE69429524T2 (de) Aminocyclohexylester und ihre anwendung
DE69726541T2 (de) 1-Aryloxy-2-arylnaphthylverbindungen, Zwischenprodukte, Zusammensetzungen und Verfahren
DE69633679T2 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
DE69628246T2 (de) Naphthyl- und Dihydronaphthylverbindungen als Arzneimittel
DE69227612T2 (de) Hexahydrobenzo(f)quinolinone als 5-alpha-reduktase Inhibitoren
DE69510192T2 (de) Substituierte cyclopentylaminderivate und deren verwendung als calcium-kanal antagonisten
DE69116237T2 (de) Derivate von Hexahydroazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP1286957A1 (de) Diphenylmethanderivate
DE69707611T2 (de) Dihydronaphthalen- und Naphthalenderivate, Zwischenverbindungen, Zusammensetzungen und deren Herstellungsverfahren
DE69708418T2 (de) Naphthylverbindungen und Zusammensetzungen
EP0591583B1 (en) Benzo (f) quinolinones as 5-alpha-reductase inhibitors
DE69014930T2 (de) Aralkylamin-Verbindungen.
DE2463023C2 (de) S-Triazolo-[5,1-a]-isochinolinderivate, deren Salze und Verfahren zu deren Herstellung
DE68908829T2 (de) Anti-Androgen-Derivate.
DE69808169T2 (de) Indene-Derivate mit SERM-Wirkung
DE69711527T2 (de) Benzofluorenverbindungen, Zwischenverbindungen, Zusammensetzungen und Verfahren
EP0591582B1 (en) Hexahydrobenzo (f) quinolinones as 5-alpha-reductase inhibitors
DE60202954T2 (de) Tetrahydrochinolin-derivate zur behandlung von krankheiten ausgelöst durch zu hohem oder zu niedrigem oestrogenspiegel
DE69307210T2 (de) Cycloalkylalkylamine als Liganden für sigma-Rezeptoren, Verfahren und ihre Herstellung und ihre Anwendung in der Therapie
DE69834388T2 (de) Hexahydroindenopyridinverbindungen mit antispermatogener aktivität
DE69723187T2 (de) Dihydrobenzofluorenverbindungen, Zwischenprodukte, Zusammensetzungen und Methode
DE69711528T2 (de) Naphthofluorenverbindungen, Zwischenverbindungen, Zusammensetzungen und Verfahren
DE19934321A1 (de) Naphthyl-substituierte Sulfonamide
DE69124519T2 (de) Spiro[cycloalkylbenzen-1,1'-(1',2',3',4'-tetrahydroisoquinoline)] mit neuroprotektiven eigenschaften

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee